Cargando…
Noninvasive prenatal testing for β-thalassemia by targeted nanopore sequencing combined with relative haplotype dosage (RHDO): a feasibility study
Noninvasive prenatal testing (NIPT) for single gene disorders remains challenging. One approach that allows for accurate detection of the slight increase of the maternally inherited allele is the relative haplotype dosage (RHDO) analysis, which requires the construction of parental haplotypes. Recen...
Autores principales: | Jiang, Fuman, Liu, Weiqiang, Zhang, Longmei, Guo, Yulai, Chen, Min, Zeng, Xiaojing, Wang, Yang, Li, Yufan, Xian, JiaJia, Du, BoLe, Xie, Yuhuan, Ouyang, Shuming, Li, Sheng, Yang, Yinghong, Zhang, Chunsheng, Luo, Fei, Sun, Xiaofang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952549/ https://www.ncbi.nlm.nih.gov/pubmed/33707551 http://dx.doi.org/10.1038/s41598-021-85128-2 |
Ejemplares similares
-
Noninvasive prenatal diagnosis of β‐thalassemia by relative haplotype dosage without analyzing proband
por: Li, Haoxian, et al.
Publicado: (2019) -
Noninvasive prenatal testing of α-thalassemia and β-thalassemia through population-based parental haplotyping
por: Chen, Chao, et al.
Publicado: (2021) -
PolyHaplotyper: haplotyping in polyploids based on bi-allelic marker dosage data
por: Voorrips, Roeland E., et al.
Publicado: (2022) -
Clinical Service Delivery of Noninvasive Prenatal Diagnosis by Relative Haplotype Dosage for Single-Gene Disorders
por: Young, Elizabeth, et al.
Publicado: (2020) -
Haplotyping pharmacogenes using TLA combined with Illumina or Nanopore sequencing
por: Tilleman, Laurentijn, et al.
Publicado: (2022)